Avidity Biosciences Inc (RNA)
Incyte Corporation (INCY)
Incyte maakt FDA-goedkeuring bekend voor Monjuvi® (tafasitamab-cxix) in combinatie met rituximab en lenalidomide voor patiënten met recidiverend of refractair folliculair lymfoom
Incyte Corporation (INCY)
Incyte annuncia lapprovazione dellFDA di Monjuvi® (tafasitamab-cxix) in combinazione con rituximab e lenalidomide per i pazienti affetti da linfoma follicolare recidivante o refrattario
9 Meters Biopharma, Inc. (NMTRQ)
Everything We Know About Frozen 3 – Release Date and Two-Part Storyline
9 Meters Biopharma, Inc. (NMTRQ)
28 Years Later Stuns at Premiere and Sets the Stage for a Bold New Horror Trilogy
BioLife Solutions Inc (BLFS)
Biomea Fusion Inc (BMEA)
Processa Pharmaceuticals Inc. (PCSA)
Biomea Fusion Inc (BMEA)
Beyond Air (XAIR)
New Form 8-K - Beyond Air, Inc. Filed: 2025-06-18 AccNo: 0001641172-25-015650 Size: 614 KB Item 2.02: Results of Operations and Financial Condition Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 8.01: Other Events Item 9.01: Financial Statements …
Veradigm Inc (MDRX)
Veradigm to Release Business Update June 23rd and Host Investor Call June 24th
Propanc Biopharma, Inc. (PPCB)
New Form 8-K - Propanc Biopharma, Inc. Filed: 2025-06-18 AccNo: 0001641172-25-015642 Size: 384 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item 9.01: …
Ardelyx Inc. (ARDX)
New Form 8-K - ARDELYX, INC. Filed: 2025-06-18 AccNo: 0001628280-25-032172 Size: 185 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders